Evaluation of Phoenixin-14, Fibroblast Growth Factor-19, and Soluble TREM-2 as Novel Biochemical Biomarkers in the Progression of Non-Alcoholic Fatty Liver Disease to Non-Alcoholic Steatohepatitis
Crossref DOI link: https://doi.org/10.53346/wjcps.2026.8.2.0018
Published Online: 2026-06-30
Update policy: https://doi.org/10.53346/zsp.ourcrossmarkpolicy
R. Ahmad, Nermen
Mahdi, Iman Noori Mahmood